On December 8, 2025, the Health Commission of Guangdong Province and the Medical Products Administration of Guangdong Province jointly announced that Heyou Pinnacle Medical Center has been included in the fourth list of the designated institutions under the "Hong Kong and Macao Medicine and Equipment Connect" policy in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA). This marks a significant step for Heyou Pinnacle Medical Center in aligning with international resources and advancing its commitment to helping GBA residents live a health life under its people-centric approach.
Under the policy, advanced medicines and medical devices that are urgently needed in clinical settings and already available in Hong Kong and Macao, but not yet launched on the mainland, can now be introduced and used for clinical treatment at Heyou Pinnacle Medical Center upon approval. This creates a new path for GBA residents to receive international-standard treatments and premium services without leaving home.
On December 8, 2025, the Health Commission of Guangdong Province and the Medical Products Administration of Guangdong Province jointly published the Notice on Issuing the Fourth List of Designated Medical Institutions under the "Hong Kong and Macao Medicine and Equipment Connect" Policy in the Guangdong-Hong Kong-Macao Greater Bay Area.
01. Supportive Policy: Accelerating Medical Integration in the GBA
The "Hong Kong and Macao Medicine and Equipment Connect" is an innovative initiative aimed at benefiting GBA residents. It allows designated medical institutions to introduce and use urgently needed medicines and medical devices that have been launched in Hong Kong and Macao, enabling patients to access cutting-edge treatments without having to cross borders.
Under this policy, more than 100 international new drugs and advanced medical devices have been introduced so far, covering numerous fields of disease treatment, including oncology and rare diseases, offering new possibilities to thousands of patients.
Since its opening on June 28, 2024, Heyou Pinnacle Medical Center has made international high standards the core of its service philosophy. Being selected as a designated institution under this policy is a significant milestone in the center's ongoing efforts to serve the health needs of GBA residents.
02. Powerful Strength: Promoting International Healthcare
The ability to become a designated institution under the "Hong Kong and Macao Medicine and Equipment Connect" policy reflects Heyou Pinnacle Medical Center's strong expertise. The center has brought together a top-tier expert team, led by renowned professionals such as Professor Lu Jiade and Professor Yu Xinguang, with more than 90% of the members being professors, supporting a comprehensive care system.
Equipped with internationally advanced medical devices, the center has also established a rigorous system for managing pharmaceuticals and services in line with international standards. This ensures the safe and compliant introduction and use of advanced drugs and devices from Hong Kong and Macao.
The center's key strengths—"world-class experts, cutting-edge technology, exceptional services, and international integration"—align perfectly with the high-quality, personalized medical needs embodied by the "Hong Kong and Macao Medicine and Equipment Connect", laying a strong foundation for delivering outstanding healthcare services.
03. A New Beginning: Empowering Lifecycle Health Management
Being granted the "Hong Kong and Macao Medicine and Equipment Connect" qualification injects fresh momentum into Heyou Pinnacle Medical Center's international development. This directly benefits GBA residents seeking treatments of international standards as well as Hong Kong and Macao citizens who wish to receive the same premium care.
This policy will considerably enhance the center's capabilities in precision oncology, rare disease treatment, high-end health management, and other areas. Patients will no longer need to travel abroad to access these treatments; they can now access innovative drugs and therapies previously only available in Hong Kong and Macao, giving them crucial time in their fight against illness.
Building on this policy, the center will further deepen collaborations with leading medical institutions in Hong Kong, Macao, and internationally, expanding partnerships in complex case international multidisciplinary consultations (MDT), cross-border referrals, technical exchanges, and talent development. This will help create a more seamless global healthcare network.
04. Looking Ahead: Building a Health Ecosystem in the GBA
Earning the "Hong Kong and Macao Medicine and Equipment Connect" qualification marks a new chapter for Heyou Pinnacle Medical Center in its service to the GBA. The center sees this as an opportunity not only to serve as a platform for introducing and using advanced drugs and medical devices but also to become an innovative hub for the exchange of international medical technologies and their local application.
Moving forward, the center will focus on key treatment areas such as oncology and complex diseases, systematically exploring the introduction of innovative drugs and medical devices, while ensuring comprehensive patient evaluation, application, and follow-up systems are in place to maximize medical value and safety.
As the integrated development of the GBA continues to deepen, Heyou Pinnacle Medical Center will build on its high-end, international capabilities, blending cutting-edge global health technologies with compassionate, patient-focused care to elevate the region's international healthcare services, as it remains committed to improving people's health and well-being.
The "Hong Kong and Macao Medicine and Equipment Connect" policy enhances the connectivity of the GBA, opening new pathways to better health. Heyou Pinnacle Medical Center will translate the policy into tangible health benefits by leveraging its strong medical expertise and global outlook to safeguard the well-being of the region.
